Serveur d'exploration sur l'Université de Trèves

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

Identifieur interne : 001460 ( Istex/Corpus ); précédent : 001459; suivant : 001461

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

Auteurs : R. A. Dressendörfer ; C. Kirschbaum ; W. Rohde ; F. Stahl ; C. J. Strasburger

Source :

RBID : ISTEX:73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7

Abstract

Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a N-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (n = 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (n = 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.

Url:
DOI: 10.1016/0960-0760(92)90294-S

Links to Exploration step

ISTEX:73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
<author>
<name sortKey="Dressendorfer, R A" sort="Dressendorfer, R A" uniqKey="Dressendorfer R" first="R. A." last="Dressendörfer">R. A. Dressendörfer</name>
<affiliation>
<mods:affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kirschbaum, C" sort="Kirschbaum, C" uniqKey="Kirschbaum C" first="C." last="Kirschbaum">C. Kirschbaum</name>
<affiliation>
<mods:affiliation>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rohde, W" sort="Rohde, W" uniqKey="Rohde W" first="W." last="Rohde">W. Rohde</name>
<affiliation>
<mods:affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Stahl, F" sort="Stahl, F" uniqKey="Stahl F" first="F." last="Stahl">F. Stahl</name>
<affiliation>
<mods:affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Strasburger, C J" sort="Strasburger, C J" uniqKey="Strasburger C" first="C. J." last="Strasburger">C. J. Strasburger</name>
<affiliation>
<mods:affiliation>To whom correspondence should be addressed.</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0960-0760(92)90294-S</idno>
<idno type="url">https://api.istex.fr/document/73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001460</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001460</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
<author>
<name sortKey="Dressendorfer, R A" sort="Dressendorfer, R A" uniqKey="Dressendorfer R" first="R. A." last="Dressendörfer">R. A. Dressendörfer</name>
<affiliation>
<mods:affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kirschbaum, C" sort="Kirschbaum, C" uniqKey="Kirschbaum C" first="C." last="Kirschbaum">C. Kirschbaum</name>
<affiliation>
<mods:affiliation>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rohde, W" sort="Rohde, W" uniqKey="Rohde W" first="W." last="Rohde">W. Rohde</name>
<affiliation>
<mods:affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Stahl, F" sort="Stahl, F" uniqKey="Stahl F" first="F." last="Stahl">F. Stahl</name>
<affiliation>
<mods:affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Strasburger, C J" sort="Strasburger, C J" uniqKey="Strasburger C" first="C. J." last="Strasburger">C. J. Strasburger</name>
<affiliation>
<mods:affiliation>To whom correspondence should be addressed.</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Steroid Biochemistry and Molecular Biology</title>
<title level="j" type="abbrev">SBMB</title>
<idno type="ISSN">0960-0760</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">43</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="683">683</biblScope>
<biblScope unit="page" to="692">692</biblScope>
</imprint>
<idno type="ISSN">0960-0760</idno>
</series>
<idno type="istex">73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7</idno>
<idno type="DOI">10.1016/0960-0760(92)90294-S</idno>
<idno type="PII">0960-0760(92)90294-S</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0960-0760</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a N-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (n = 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (n = 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>R.A. Dressendörfer</name>
<affiliations>
<json:string>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Kirschbaum</name>
<affiliations>
<json:string>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>W. Rohde</name>
<affiliations>
<json:string>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Stahl</name>
<affiliations>
<json:string>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>C.J. Strasburger</name>
<affiliations>
<json:string>To whom correspondence should be addressed.</json:string>
<json:string>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</json:string>
</affiliations>
</json:item>
</author>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<abstract>Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a N-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (n = 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (n = 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.</abstract>
<qualityIndicators>
<score>6.713</score>
<pdfVersion>1.2</pdfVersion>
<pdfPageSize>533 x 771 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>0</keywordCount>
<abstractCharCount>1634</abstractCharCount>
<pdfWordCount>4049</pdfWordCount>
<pdfCharCount>27041</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>222</abstractWordCount>
</qualityIndicators>
<title>Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
<pii>
<json:string>0960-0760(92)90294-S</json:string>
</pii>
<refBibs>
<json:item>
<author>
<json:item>
<name>B.P. Murphy</name>
</json:item>
<json:item>
<name>W. Engelberg</name>
</json:item>
<json:item>
<name>C.J. Pattee</name>
</json:item>
</author>
<host>
<volume>23</volume>
<pages>
<last>300</last>
<first>293</first>
</pages>
<author></author>
<title>J. Clin. Endocr. Metab.</title>
</host>
<title>Simple method for the determination of plasma corticoids</title>
</json:item>
<json:item>
<author>
<json:item>
<name>W. Hubl</name>
</json:item>
<json:item>
<name>H. Taubert</name>
</json:item>
<json:item>
<name>E. Freimann</name>
</json:item>
<json:item>
<name>D. Meissner</name>
</json:item>
<json:item>
<name>F. Stahl</name>
</json:item>
<json:item>
<name>G. Doerner</name>
</json:item>
</author>
<host>
<volume>84</volume>
<pages>
<last>70</last>
<first>63</first>
</pages>
<author></author>
<title>Exp. Clin. Endocr.</title>
</host>
<title>A sensitive direct enzyme immunoassay for cortisol in plasma and saliva</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D. Riad-Fahmy</name>
</json:item>
<json:item>
<name>G.F. Read</name>
</json:item>
<json:item>
<name>R.F. Walker</name>
</json:item>
<json:item>
<name>K. Griffiths</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>395</last>
<first>367</first>
</pages>
<author></author>
<title>Endocrine Rev.</title>
</host>
<title>Steroids in saliva for assessing endocrine functions</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F.H. Katz</name>
</json:item>
<json:item>
<name>I.L. Shannon</name>
</json:item>
</author>
<host>
<pages>
<last>451</last>
<first>448</first>
</pages>
<author></author>
<title>J. Dent. Res.</title>
</host>
<title>Adrenal corticosteroids in submaxillary fluid</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R.F. Walker</name>
</json:item>
<json:item>
<name>D. Riad-Fahmy</name>
</json:item>
<json:item>
<name>G.F. Read</name>
</json:item>
</author>
<host>
<volume>24</volume>
<pages>
<last>1463</last>
<first>1460</first>
</pages>
<author></author>
<title>Clin. Chem.</title>
</host>
<title>Adrenal status assessed by direct radioimmunoassay of cortisol in whole saliva or amniotic fluid</title>
</json:item>
<json:item>
<author>
<json:item>
<name>P.J. Evans</name>
</json:item>
<json:item>
<name>J.R. Peters</name>
</json:item>
<json:item>
<name>J. Dyhs</name>
</json:item>
<json:item>
<name>R.F. Walker</name>
</json:item>
<json:item>
<name>D. Riad-Fahmy</name>
</json:item>
<json:item>
<name>R. Hall</name>
</json:item>
</author>
<host>
<volume>20</volume>
<pages>
<last>715</last>
<first>709</first>
</pages>
<author></author>
<title>Clin. Endocr.</title>
</host>
<title>Salivary cortisol levels in true and apparent hypercortisolism</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C.A. Moore</name>
</json:item>
<json:item>
<name>G.K. Stalla</name>
</json:item>
<json:item>
<name>O.A. Müller</name>
</json:item>
</author>
<host>
<volume>324</volume>
<pages>
<first>260</first>
</pages>
<author></author>
<title>Fresenius Z. Analyt. Chem.</title>
</host>
<title>Value of a saliva cortisol radioimmunoassay in the testing of the hypothalamic-pituitary-adrenal axis</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R.M. Rose</name>
</json:item>
<json:item>
<name>M.W. Hurst</name>
</json:item>
</author>
<host>
<volume>1</volume>
<pages>
<last>36</last>
<first>22</first>
</pages>
<author></author>
<title>J. Hum. Stress</title>
</host>
<title>Plasma cortisol and human growth hormone responses to intravenous cathererisation</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. Kirschbaum</name>
</json:item>
<json:item>
<name>D.H. Hellhammer</name>
</json:item>
</author>
<host>
<volume>22</volume>
<pages>
<last>169</last>
<first>150</first>
</pages>
<author></author>
<title>Neuropsychobiology</title>
</host>
<title>Salivary cortisol in psychobiological research: an overview</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>T. Ternynck</name>
</json:item>
<json:item>
<name>S. Avrameas</name>
</json:item>
</author>
<host>
<author></author>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</host>
<serie>
<author></author>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</serie>
<title>Avidin-biotin system in enzyme immunoassays</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C.J. Strasburger</name>
</json:item>
<json:item>
<name>F. Kohen</name>
</json:item>
</author>
<host>
<author></author>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</host>
<serie>
<author></author>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</serie>
<title>Two-site and competitive chemiluminescent immunoassays</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B. Manz</name>
</json:item>
<json:item>
<name>A. Heubner</name>
</json:item>
<json:item>
<name>I. Köhler</name>
</json:item>
<json:item>
<name>H.-J. Grill</name>
</json:item>
<json:item>
<name>K. Pollow</name>
</json:item>
</author>
<host>
<volume>131</volume>
<pages>
<last>338</last>
<first>333</first>
</pages>
<author></author>
<title>Eur. J. Biochem.</title>
</host>
<title>Synthesis of biotin-labelled dexamethasone derivatives</title>
</json:item>
<json:item>
<author>
<json:item>
<name>H.H.D. Meyer</name>
</json:item>
<json:item>
<name>H. Sauerwein</name>
</json:item>
<json:item>
<name>B.M. Mutayoba</name>
</json:item>
</author>
<host>
<volume>35</volume>
<pages>
<last>269</last>
<first>263</first>
</pages>
<author></author>
<title>J. Steroid Biochem.</title>
</host>
<title>Immunoaffinity chromatography and a biotin-streptavidin amplified enzyme immunoassay for sensitive and specific estimation of estradiol-17β</title>
</json:item>
<json:item>
<author>
<json:item>
<name>L.X. Tiefenauer</name>
</json:item>
<json:item>
<name>R.Y. Andres</name>
</json:item>
</author>
<host>
<volume>35</volume>
<pages>
<last>639</last>
<first>633</first>
</pages>
<author></author>
<title>J. Steroid Biochem.</title>
</host>
<title>Biotinyl-estradiol derivatives in enzyme immunoassays: structural requirements for optimal antibody binding</title>
</json:item>
<json:item>
<author></author>
<host>
<author></author>
<title>B 82.10</title>
</host>
<title>Amtliche Sammlung von Untersuchungsverfahren nach §35 LMBG</title>
</json:item>
<json:item>
<author>
<json:item>
<name>E. Soini</name>
</json:item>
</author>
<host>
<pages>
<last>208</last>
<first>197</first>
</pages>
<author></author>
<title>Monoclonal Antibodies and New Trends in Immunoassays</title>
</host>
<title>Pulsed light, time-resolved fluorometric immunoassay</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C. Kirschbaum</name>
</json:item>
<json:item>
<name>C.J. Strasburger</name>
</json:item>
<json:item>
<name>W. Jammers</name>
</json:item>
<json:item>
<name>D.H. Hellhammer</name>
</json:item>
</author>
<host>
<volume>34</volume>
<pages>
<last>751</last>
<first>747</first>
</pages>
<author></author>
<title>Pharmac. Biochem. Behav.</title>
</host>
<title>Cortisol and Behavior: 1. Adaptation of a radioimmunoassay kit for reliable and inexpensive salivary cortisol determination</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G.L. Hammond</name>
</json:item>
<json:item>
<name>M.S. Langley</name>
</json:item>
</author>
<host>
<volume>112</volume>
<pages>
<last>608</last>
<first>603</first>
</pages>
<author></author>
<title>Acta Endocr.</title>
</host>
<title>Identification and measurement of sex hormone binding globulin (SHBG) and corticosteroid binding globulin (CBG) in human saliva</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M.J. Khosravi</name>
</json:item>
<json:item>
<name>R.C. Morton</name>
</json:item>
</author>
<host>
<volume>37</volume>
<pages>
<last>63</last>
<first>58</first>
</pages>
<author></author>
<title>Clin. Chem.</title>
</host>
<title>Novel application of streptavidin-hapten derivatives as protein-tracer conjugate in competitive-type immunoassays involving biotinylated detection probes</title>
</json:item>
</refBibs>
<genre>
<json:string>research-article</json:string>
</genre>
<serie>
<volume>Vol. 184</volume>
<pages>
<last>481</last>
<first>469</first>
</pages>
<language>
<json:string>unknown</json:string>
</language>
<title>Methods in Enzymology: Avidin-biotin Technology</title>
</serie>
<host>
<volume>43</volume>
<pii>
<json:string>S0960-0760(00)X0128-8</json:string>
</pii>
<pages>
<last>692</last>
<first>683</first>
</pages>
<issn>
<json:string>0960-0760</json:string>
</issn>
<issue>7</issue>
<genre>
<json:string>journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Journal of Steroid Biochemistry and Molecular Biology</title>
<publicationDate>1992</publicationDate>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>endocrinology & metabolism</json:string>
<json:string>biochemistry & molecular biology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>endocrinology & metabolism</json:string>
</scienceMetrix>
</categories>
<publicationDate>1992</publicationDate>
<copyrightDate>1992</copyrightDate>
<doi>
<json:string>10.1016/0960-0760(92)90294-S</json:string>
</doi>
<id>73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7</id>
<score>0.3396452</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>ELSEVIER</p>
</availability>
<date>1992</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
<author xml:id="author-1">
<persName>
<forename type="first">R.A.</forename>
<surname>Dressendörfer</surname>
</persName>
<affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</affiliation>
</author>
<author xml:id="author-2">
<persName>
<forename type="first">C.</forename>
<surname>Kirschbaum</surname>
</persName>
<affiliation>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">W.</forename>
<surname>Rohde</surname>
</persName>
<affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</affiliation>
</author>
<author xml:id="author-4">
<persName>
<forename type="first">F.</forename>
<surname>Stahl</surname>
</persName>
<affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</affiliation>
</author>
<author xml:id="author-5">
<persName>
<forename type="first">C.J.</forename>
<surname>Strasburger</surname>
</persName>
<affiliation>To whom correspondence should be addressed.</affiliation>
<affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Journal of Steroid Biochemistry and Molecular Biology</title>
<title level="j" type="abbrev">SBMB</title>
<idno type="pISSN">0960-0760</idno>
<idno type="PII">S0960-0760(00)X0128-8</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1992"></date>
<biblScope unit="volume">43</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="683">683</biblScope>
<biblScope unit="page" to="692">692</biblScope>
</imprint>
</monogr>
<idno type="istex">73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7</idno>
<idno type="DOI">10.1016/0960-0760(92)90294-S</idno>
<idno type="PII">0960-0760(92)90294-S</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1992</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a N-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (n = 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (n = 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.</p>
</abstract>
</profileDesc>
<revisionDesc>
<change when="1992">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla">
<item-info>
<jid>SBMB</jid>
<aid>9290294S</aid>
<ce:pii>0960-0760(92)90294-S</ce:pii>
<ce:doi>10.1016/0960-0760(92)90294-S</ce:doi>
<ce:copyright type="unknown" year="1992"></ce:copyright>
</item-info>
<head>
<ce:title>Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>R.A.</ce:given-name>
<ce:surname>Dressendörfer</ce:surname>
<ce:cross-ref refid="AFF1">
<ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>C.</ce:given-name>
<ce:surname>Kirschbaum</ce:surname>
<ce:cross-ref refid="AFF2">
<ce:sup>2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>W.</ce:given-name>
<ce:surname>Rohde</ce:surname>
<ce:cross-ref refid="AFF3">
<ce:sup>3</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>F.</ce:given-name>
<ce:surname>Stahl</ce:surname>
<ce:cross-ref refid="AFF3">
<ce:sup>3</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>C.J.</ce:given-name>
<ce:surname>Strasburger</ce:surname>
<ce:cross-ref refid="COR1">
<ce:sup></ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF1">
<ce:sup>1</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF3">
<ce:label>c</ce:label>
<ce:textfn>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</ce:textfn>
</ce:affiliation>
<ce:correspondence id="COR1">
<ce:label></ce:label>
<ce:text>To whom correspondence should be addressed.</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="2" month="12" year="1991"></ce:date-received>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>Cortisol 3-(
<ce:italic>o</ce:italic>
-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a
<ce:italic>N</ce:italic>
-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (
<ce:italic>n</ce:italic>
= 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (
<ce:italic>n</ce:italic>
= 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement</title>
</titleInfo>
<name type="personal">
<namePart type="given">R.A.</namePart>
<namePart type="family">Dressendörfer</namePart>
<affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Kirschbaum</namePart>
<affiliation>Fachbereich I Psychologie, Universität Trier, 5500 Trier-Tarforst, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">W.</namePart>
<namePart type="family">Rohde</namePart>
<affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Stahl</namePart>
<affiliation>Institut für Experimentelle Endokrinologie, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin, Schumannstraβe 20/21, 1040 Berlin, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.J.</namePart>
<namePart type="family">Strasburger</namePart>
<affiliation>To whom correspondence should be addressed.</affiliation>
<affiliation>Medizinische Klinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Ziemssenstraβe 1, 8000 München 2, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1992</dateIssued>
<copyrightDate encoding="w3cdtf">1992</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">Cortisol 3-(o-carboxymethyl)oxime (C3-CMO) and a commercially available biotin-hydrazide derivative were used to synthesize a C3-CMO-biotin conjugate. C3-CMO was converted into a N-hydroxysuccinimide ester derivative which in a second reaction step was allowed to interact with the hydrazide derivative of biotin. This simple-to-perform synthesis yielded a conjugate suitable for use as a tracer in immunoassays for cortisol measurement. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for variable end point determination by means of commercially available labeled avidin or streptavidin derivatives. Streptavidin-Europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA) throughout the study. In addition, colorimetric end point determination (ELISA) using streptavidin-alkaline phosphatase as a secondary probe was established and evaluated. Both forms of this non-isotopic assay showed excellent correlation with a commercially available radioimmunoassay adapted for salivary cortisol measurement. The lower detection limit was 0.43 nM for a 50 μl salivary sample. The intra-assay coefficient of variation was 6.7, 4.7 and 4.0% at cortisol concentrations of 2.2, 5.5 and 13.2 nM, respectively (n = 37), and the corresponding inter-assay coefficients of variation were 9.0, 8.6 and 7.1% (n = 50). The competitive immunoassay requires 1.5 h incubation time and shows robust and reproducible performance. The C3-CMO-biotin conjugate allows for sensitive and flexible end point determination of salivary cortisol levels in immunoassays.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Journal of Steroid Biochemistry and Molecular Biology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>SBMB</title>
</titleInfo>
<genre type="journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">199212</dateIssued>
</originInfo>
<identifier type="ISSN">0960-0760</identifier>
<identifier type="PII">S0960-0760(00)X0128-8</identifier>
<part>
<date>199212</date>
<detail type="volume">
<number>43</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>7</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>599</start>
<end>743</end>
</extent>
<extent unit="pages">
<start>683</start>
<end>692</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7</identifier>
<identifier type="DOI">10.1016/0960-0760(92)90294-S</identifier>
<identifier type="PII">0960-0760(92)90294-S</identifier>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
</recordInfo>
</mods>
</metadata>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001460 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001460 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Rhénanie
   |area=    UnivTrevesV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:73592A6264FB200B44EB3A3DC6BBCFB83BF3C8B7
   |texte=   Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Jul 22 16:29:01 2017. Site generation: Wed Feb 28 14:55:37 2024